News

BMG LABTECH today announced the launch of a newly redesigned version of its website. The site's clean and modern look, combined with improved search functionality, and optimization for mobile devices allow visitors to better interact with BMG LABTECH online.

BMG LABTECH announces that the company has received grant for the U.S. Patent 9,733,124, entitled “Microplate Reader with Linear Variable Filter”. The patent’s claims cover a revolutionary new type of dual monochromator technology using Linear Variable Filters (LVF) for the selection of wavelength and bandwidths. The patent provides protection for this unique LVF Monochromator^TM design and recognition of the high quality of the innovation being carried out by the BMG LABTECH team.

BMG LABTECH developed a new gas ramping function that can fully manipulate the environment within a microplate reader, by mimicking in vitro hypoxia and ischaemia/reperfusion. Equipped with this unique feature, the CLARIOstar^® with Atmospheric Control Unit (ACU) is the first plate reader that is able to rapidly return to physiological gas conditions upon active modification of oxygen (0₂) and carbon dioxide (CO₂) tensions within the reader, reproducing disease-specific settings in live cell-based assays. The use of conditions that resemble as close as possible physiological or pathological conditions results in more reliable in vitro data that better translate to in vivo situations.

Next Generation Sequencing (NGS) has become a powerful tool to investigate genetic changes that lead to cancer or diseases. DNA quantification is essential for NGS, where precise amounts of DNA are required. With its highly sensitive microplate readers, BMG LABTECH helps to accurately quantify DNA and ensure the required precision. The versatile multi-mode microplate readers are equipped with an ultrafast UV/vis spectrometer for fast quality and quantity determinations as well as unique technologies for high throughput fluorescence DNA quantification.

The European technology SME’s BMG LABTECH GmbH, Luxcel Biosciences und Axiogenesis AG will exhibit at the EMBL Symposium: Metabolism in Time and Space in Heidelberg, Germany May 11-13, 2017.